The Discovery
The Mysterious Killer in the Cheese Vat
A Discovery by Accident
Key moment
Rogers observed bacteria in cheese cultures with mysterious killing power—nobody realized its importance yet.
In 1928, in an English cheese factory laboratory, a scientist named Rogers faced a frustrating problem. Cheesemakers add special bacterial starter cultures to milk to help turn it into cheese. But sometimes certain batches mysteriously killed off these starter cultures. Rogers and colleagues studied why this kept happening.
They noticed the milk came from cultures with a specific lactic acid bacteria—bacteria that lived peacefully in dairy products. These bacteria, called Group N Streptococcus, seemed to have a secret weapon. When Rogers tested them against other microorganisms, they killed them. Nobody understood how or why. It was just an interesting observation. Other researchers had noticed this before, but nobody paid attention.
Rogers's careful documentation of this 'Group N inhibitory substance' would become important decades later. That same year, Alexander Fleming discovered penicillin—the first modern antibiotic that changed medicine forever. But Rogers's discovery, though quiet and unnoticed at first, would eventually prove just as important for feeding and protecting people in a completely different way.
The Breakthrough
From 'Group N Substance' to 'Nisin'
Scientists Give It a Name and Figure Out What It Does
Key moment
Scientists identified nisin as a protein and Aplin & Barrett commercialized it as 'Nisaplin' in 1953.
For twenty years after Rogers's discovery, scientists remained puzzled. What was this substance in milk bacteria? Was it a protein? A chemical? How did it kill other bacteria? Researchers slowly worked to purify the mysterious inhibitory substance, testing and measuring it. They discovered it was a protein—a chain of amino acids folded into a specific shape.
Cheesemakers knew it was useful for keeping cultures stable. Some companies began experimenting with using these bacteria to prevent food spoilage. Then World War II disrupted scientific research worldwide. After the war, when research resumed, scientists had better tools for studying proteins carefully. Gradually, they realized this wasn't just any protein—it had unusual ring-shaped bonds that were rare in nature. They named it 'nisin,' and by the 1950s, scientists understood it was special.
In 1953, a company called Aplin & Barrett in England realized they could use this discovery commercially. They created a product called 'Nisaplin' and began selling it to food manufacturers. Nisin could keep cheese, butter, and dairy products from spoiling. It was safe, came from natural bacteria, and actually worked. But getting government approval would take much longer.
The Trials
The Long Road to FDA Approval
Proving It Was Safe Took Thirty Years
Key moment
FDA grants nisin GRAS status in 1983 after decades of safety testing.
From the 1950s to 1970s, scientists conducted careful, slow testing. They had to prove nisin was not just effective but completely safe for humans to eat. The FDA doesn't approve food additives quickly. Researchers studied nisin for decades. They tested what happened when people and animals ate it. They checked for allergies, cancer, or any harm. They studied how the body broke it down. They tested it in different foods. Companies manufacturing nisin had to show the FDA exactly how they made it and prove the product was pure. This took enormous effort and cost millions of dollars.
By the 1970s and 1980s, scientific evidence was overwhelming. Nisin was safe. It had been used safely in Europe and other countries for years. In 1983, the FDA finally granted nisin 'GRAS' status—'Generally Recognized As Safe.' This was a major milestone. It meant nisin could be used in cheese and other dairy products in the United States. The European Union also classified it as food additive E234. Slowly, nisin gained approval in country after country.
By the 2000s, nisin was being used legally in more than 50 countries worldwide. It became the only antimicrobial peptide—the only protein made by bacteria to kill other bacteria—approved for routine food use globally.
The Crisis
From Cheese to the Operating Room
Scientists Discover Nisin Might Fight Dangerous Hospital Infections
Key moment
Researchers discover nisin kills MRSA and works with antibiotics to fight resistant infections.
By the 1990s, a serious problem grew in hospitals. Bacteria like Staphylococcus aureus (staph) became resistant to antibiotics. Doctors gave patients more antibiotics, but some bacteria survived and mutated. One particularly dangerous form was MRSA—methicillin-resistant Staphylococcus aureus. MRSA caused skin infections, pneumonia, and life-threatening bloodstream infections. Antibiotics that once worked simply didn't work anymore.
Doctors became desperate and looked for new weapons. Some scientists remembered nisin. Here was a protein that had been killing bacteria safely for fifty years in food. What if it could fight drug-resistant bacteria? Researchers began testing nisin in the laboratory. They discovered something exciting: nisin could attack MRSA. It punched holes in the bacteria's cell walls and destroyed them. Better yet, when combined with certain antibiotics, the effect was even stronger. Nisin made the bacteria vulnerable, and the antibiotic finished them off. Researchers tested nisin in wound dressings for treating infected cuts and burns. They tested it against biofilms—slimy communities of bacteria protecting themselves from antibiotics by clumping together. Nisin could break apart these biofilm fortresses.
Studies showed that nisin wasn't toxic to human cells at medical doses. The research was promising. What had been a simple food preservative was transforming into a potential hospital medicine.
The Legacy
The Future: From Food to Medicine
Opening the Door to Curing Infections
Key moment
Nisin transitions from food preservative to potential medicine for serious infections and antibiotic resistance.
Today, nisin is at a turning point. For nearly a century, it has been a trusted food preservative—a quiet guardian keeping cheese and dairy safe. But now scientists ask bigger questions. Can nisin treat serious infections? Can it heal chronic wounds? Could it fight certain diseases? Research continues in universities and hospitals worldwide. Scientists test nisin-coated wound dressings that slowly release the protein to fight bacteria. They study how nisin could treat mastitis—an infection in dairy cows costing billions. Some explore whether nisin prevents biofilms in medical devices like catheters. Others investigate how it works in combination therapies where nisin weakens bacteria and other drugs finish the job.
The reason nisin is so promising is simple: bacteria have had a much harder time developing resistance to it. Nisin uses a completely different mechanism than traditional antibiotics. It doesn't poison a specific enzyme or block a specific pathway. Instead, nisin punctures the cell wall itself—like creating a hole in a balloon. Bacteria can't easily mutate around that problem. As antibiotic resistance grows worse and hospitals struggle with superbugs, nisin offers new hope.
The future isn't certain, but the possibility is real: a substance discovered by accident in cheese cultures in 1928 might help doctors save lives from dangerous infections in the 21st century. That's the power of basic science and patient investigation.
Peptide history · 1928
Nisin A Lantibiotic Bacteriocin
A bacteria-made protein from cheese that kills superbugs without creating resistance.
Nisin is a tiny protein made by milk bacteria discovered in 1928. For 70 years it kept food safe as a preservative. Today scientists test it against deadly drug-resistant bacteria like MRSA. This remarkable discovery shows how nature's solutions can protect both food and human health.
Rogers and Whittier found it in English cheese factory cultures
Building blocks arranged with 3 special ring-shaped bonds
Daltons measure atomic mass units in molecules
Generally Recognized As Safe for food preservation
Used legally worldwide as food additive E234 in EU
Compound classification
Rogers and Whittier
The Discoverers · English Cheese Factory Laboratory
In 1928, Rogers and Whittier noticed that lactic acid bacteria killed other starter cultures in cheese. This accidental observation led to discovering what would become nisin. Their careful documentation opened an entire field of research into natural antimicrobial peptides.
Certain batches of milk mysteriously inhibited the growth of other cultures—a phenomenon that would reshape food preservation.
A.T.R. Mattick
Early Pioneer Researcher · University Research Labs
Part of the team that characterized the mysterious 'Group N Inhibitory Substance' in the 1930s. Mattick helped establish that the substance was protein-based and worked through cell wall disruption, not chemical poisoning.
This inhibitory substance appears to be a protein with unusual structural properties unlike any known antibiotic.
Aplin & Barrett Company
First Commercial Producer · English Food Industry Pioneer
In 1953, Aplin & Barrett created 'Nisaplin'—the first commercial nisin product. They made nisin available to food manufacturers worldwide, transforming it from laboratory curiosity into practical tool for food safety.
We took a laboratory discovery and made it work in real factories, feeding real people.
E.K. Gross and Morell
Structure Discoverers · Molecular Biology Research Teams
In 1971, Gross and Morell determined nisin's exact three-dimensional structure. They revealed the ring-shaped lanthionine bonds that make nisin unique and stable—explaining why it outlasts other proteins.
The ring-shaped bonds create a cage-like structure that nature rarely produces outside of lantibiotics.
Modern Biomedical Researchers
MRSA and Clinical Pioneers · University Hospitals and Research Centers
Since 2000, researchers tested nisin against drug-resistant bacteria like MRSA and explored wound healing applications. They discovered nisin kills resistant bacteria and breaks apart protective biofilms. Their work suggests nisin could treat dangerous infections as hospitals face antibiotic resistance.
What began as a food preservative shows remarkable promise against infections that modern medicine struggles to treat.
12 milestones, 1928 – 2023.
- 1928Rogers and Whittier discover 'Group N inhibitory substance' in lactic acid bacteria cultures during cheese production research in England.
- 1930Early characterization begins. Scientists establish the substance is protein-like with unusual structural properties.
- 1953Aplin & Barrett Company (England) begins commercial production under brand name 'Nisaplin' for food preservation.
- 1960Nisin gains approval for use in various countries and food types, becoming more widely available to food manufacturers.
- 1970Safety studies intensify as FDA and regulatory bodies prepare to evaluate nisin for wider approval in the United States.
- 1971E.K. Gross and colleagues determine nisin's exact three-dimensional structure, revealing the ring-shaped lanthionine bonds.
- 1983FDA grants nisin 'GRAS' (Generally Recognized As Safe) status, enabling legal use as food preservative in the United States.
- 1990European Union classifies nisin as food additive E234, furthering its international regulatory acceptance.
- 2000Scientists begin formal research into nisin's potential against antibiotic-resistant bacteria including MRSA.
- 2009Multiple peer-reviewed studies confirm nisin's effectiveness against methicillin-resistant Staphylococcus aureus in laboratory and animal models.
- 2015Research demonstrates nisin-loaded nanofiber wound dressings can treat Staphylococcus aureus-induced skin infections in animal models.
- 2023Advanced research clarifies how nisin's ring-shaped structure enables it to penetrate bacterial defenses more effectively than traditional antibiotics.
Nisin is like a tiny molecular assassin created by bacteria to protect themselves. It's a chain of 34 amino acids with special ring-shaped bonds that make it incredibly stable. When nisin finds bacteria, it works like a needle poking a balloon—it punctures the cell wall causing the bacterium to die. Unlike chemical antibiotics that poison specific pathways, nisin uses physical destruction bacteria can't easily evolve resistance against.
Molecular structure
- Amino Acids
- 34
- Molecular Weight
- 3,354 Da
- Structure
- Lantibiotic with lanthionine rings
- Source
- Lactococcus lactis
Nisin has been used in food since 1953 with virtually no resistance development or toxicity issues.
Nisin is legally approved and used as a food preservative on six continents.
MRSA kills approximately 20,000 Americans per year. Nisin offers potential new treatment options.
Nisin's small size and simple structure make it relatively easy to study and produce compared to larger protein drugs.
Real stories, real lives
Sarah M., Age 45
Sarah contracted MRSA from a hospital patient during routine care. Standard antibiotics failed to clear her skin infection. Her doctor explained experimental treatments using nisin-based wound dressings. After two weeks of treatment, the infection began healing. Sarah's case demonstrates how 70-year-old food preservative might treat modern infections that antibiotics no longer control.
James T., Age 28
James suffered a serious burn requiring surgery. Post-operative infection with drug-resistant staph threatened his recovery. Nisin-coated dressing trials were suggested. Combined with careful wound care, the infection cleared. James recovered full mobility. His case shows nisin's potential for healing wounds complicated by antibiotic-resistant bacteria.
The future of Nisin
- Medical Device CoatingsActive Research
Scientists are coating catheters and surgical devices with nisin to prevent infections during hospitalization. This could reduce hospital-acquired infections affecting millions of patients.
- Wound Healing TherapiesClinical Trials Progressing
Nisin-loaded dressings and bandages are being tested for chronic wounds, burns, and surgical sites. Early results show promise for faster healing with reduced infection risk.
- Combination Antibiotic TreatmentsResearch Phase
Scientists combine nisin with traditional antibiotics to restore effectiveness against resistant bacteria. This strategy uses less antibiotic while achieving better results.
- Oral and Injectable FormulationsEarly Development
Researchers explore nisin pills and injections for internal infections like mastitis in dairy cows and potentially human bloodstream infections.
Be inspired
The story of Nisin is ultimately about the relentless pursuit of better medicine for humanity.
Continue the legacy. The next breakthrough could be yours.